Sort
4,870 grants matching “glp 1”
Targeted formulations of GLP -1 for Type 1 diabetes
$500,945Pharmain Corporation · R43 · FY2004 · DK
Aging Intervention Studies
$500,907Julie Mattison · National Institute On Aging · ZIA · FY2016 · AG
Parsing the central control of thirst and hunger using a rat model of diabetes insipidus
$500,478Derek Daniels · State University Of New York At Buffalo · R01 · FY2022 · DK
Project 5: IND-enabling Critical Path Project: GMP Manufacture of a Combination I
$500,246Amanda Malone · Oak Crest Institute Of Science · U19 · FY2017 · AI
Targeted Nanoparticles of Bismuth Organo Complexes for Spectral CT Imaging of Cor
$500,010Y Andrew Wang · Ocean Nanotech, Llc · R42 · FY2014 · HL
Multifunctional Hollow Gold Nanospheres for Concurrent Photothermal-Chemotherapy
$500,000Y Andrew Wang · Ocean Nanotech, Llc · R44 · FY2016 · CA
Multifunctional Hollow Gold Nanospheres for Concurrent Photothermal-Chemotherapy
$500,000Y Andrew Wang · Ocean Nanotech, Llc · R44 · FY2015 · CA
Comparative Effectiveness of Medical Therapy vs. Bariatric Surgery for Obese T2DM
$500,000David Bradley Lautz · Brigham And Women'S Hospital · RC1 · FY2010 · DK
LASER TISSUE WELDING: BREACHING BARRIERS IN THE SURGICAL MANAGEMENT OF THE PANCREAS
$500,000Yasmin Wadia · Laser Tissue Welding, Inc. · R44 · FY2017 · CA
Definitive (GLP) Toxicity and Toxicology Studies for a Novel Small Molecule for Protection Against Cardiotoxicity in Triple Negative Breast Cancer
$500,000Cathy A Swindlehurst · Novomedix, Inc. · SB1 · FY2024 · HL
Sutra TMVR delivery system development and V&V testing
$500,000Thuy M Pham · Sutra Medical, Inc. · SB1 · FY2021 · HL
Comparative Effectiveness of Medical Therapy vs. Bariatric Surgery for Obese T2DM
$500,000David Bradley Lautz · Brigham And Women'S Hospital · RC1 · FY2009 · DK
LASER TISSUE WELDING: BREACHING BARRIERS IN THE SURGICAL MANAGEMENT OF THE PANCREAS
$500,000Yasmin Wadia · Laser Tissue Welding, Inc. · R44 · FY2016 · CA
A PROOF-OF-CONCEPT CLINICAL TRIAL OF XENIN-25 IN THE TREATMENT OF TYPE 2 DIABETES
$499,999Kenneth S Polonsky · Washington University · RC1 · FY2009 · DK
Lifestyle Change Implementation Research Network at PRC at UMass Chan
$499,993Jamie Faro · Univ Of Massachusetts Med Sch Worcester · U48 · FY2025 · DP
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$499,989D. Martin Watterson · Northwestern University At Chicago · U01 · FY2015 · AG
Drug Development of GLP-1 receptor agonists
$499,918Josephine Egan · National Institute On Aging · ZIA · FY2013 · AG
A 13-Week Oral Gavage Toxicity Study of OLX-07010 in Beagle Dogs Followed by a 4-Week Recovery Period
$499,879James G. Moe · Oligomerix, Inc · R44 · FY2025 · AG
De-risking ONL1204 to enable venture capital investment for first-in-human clinical trials
$499,844Jana Van De Goor · Onl Therapeutics, Inc. · SB1 · FY2018 · EY
Two-for-one Stroke Thrombectomy: A novel Dual DAC to enhance navigability, lumen size, aspiration efficiency, and persistent flow arrest in mechanical thrombectomy
$499,765David F Kallmes · Piraeus Medical, Inc. · R41 · FY2023 · NS
De-risking ONL1204 to enable venture capital investment for first-in-human clinical trials
$499,761Jana Van De Goor · Onl Therapeutics, Inc. · SB1 · FY2017 · EY
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)
$499,709Zachary Rome · Timber Pharmaceuticals, Llc · R01 · FY2020 · FD
Targeted formulations of GLP -1 for Type 1 diabetes
$499,654Pharmain Corporation · R43 · FY2005 · DK
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)
$499,580Zachary Rome · Timber Pharmaceuticals, Llc · R01 · FY2021 · FD
GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular
$499,545Jeremy Riley · Proneurogen, Inc. · R43 · FY2023 · AG